VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ABVC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ABVCABVC BioPharma, Inc.
$1.57$23M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksABVCQuarterly Financials

ABVC BioPharma, Inc. (ABVC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

ABVC BioPharma, Inc. (ABVC) quarterly income statement — complete revenue, gross profit & net income history

ABVC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue0-795.95K0001.97K389.28K117.14K1.21K2.17K15.88K6.11K128.27K588.99K42.27K312.86K25.66K-37.79K99K31.44K
Revenue Growth %--40585.76%-100%-100%-100%-9.19%2350.74%1817.53%-99.06%-99.63%-62.42%-98.05%399.89%1658.47%-57.3%895.07%-90.25%-160.77%-14.33%-86.12%
Cost of Goods Sold92.16K00000296190277139.21K29.61K72.98K60.24K265.41K10.74K8.37K1.9K2.8K393646
COGS % of Revenue------0.08%0.16%22.99%6429.84%186.44%1194.65%46.96%45.06%25.41%2.67%7.39%-7.41%0.4%2.05%
Gross Profit-92.16K-795.95K0001.97K388.98K116.95K928-137.04K-13.73K-66.87K68.04K323.58K31.53K304.49K23.76K-40.59K98.61K30.8K
Gross Margin %-100%---100%99.92%99.84%77.01%-6329.84%-86.44%-1094.65%53.04%54.94%74.59%97.33%92.61%107.41%99.6%97.95%
Gross Profit Growth %--40585.76%-100%-100%-100%101.43%2933.07%274.89%-98.64%-142.35%-143.55%-121.96%186.3%897.1%-68.03%888.77%-90.93%-167.33%-7.79%-86.15%
Operating Expenses1.48M2.2M1.96M2.29M693K336.12K339.03K977.06K2.84M1.82M2.14M2.13M1.97M3.46M3.75M2.35M6.24M6.41M2.07M2.07M
OpEx % of Revenue--276.26%---17096.85%87.09%834.08%235616.85%84275.7%13479.87%34816.99%1539.09%586.86%8865.53%751.57%24327.69%-16951.71%2090.08%6572.02%
Selling, General & Admin1.45M2.17M1.93M2.26M664.14K304.14K301.21K944.18K2.77M1.75M2M1.61M1.64M1.96M3.44M1.82M5.88M6.15M1.81M1.71M
SG&A % of Revenue--272.61%---15470.19%77.38%806.01%229885.23%80941.52%12590.24%26395.94%1277.94%332.9%8142.81%581.27%22927.05%-16263.25%1823.99%5430.59%
Research & Development33.1K29.06K29.89K33.28K28.86K31.98K37.83K40.4K69.07K72.19K141.31K514.44K334.98K1.5M305.48K532.78K359.4K260.19K263.42K358.88K
R&D % of Revenue--3.65%---1626.65%9.72%34.49%5731.62%3334.18%889.64%8421.05%261.15%253.96%722.71%170.29%1400.64%-688.46%266.09%1141.43%
Other Operating Expenses0000000-7.52K000000000000
Operating Income-1.57M-2.99M-1.96M-2.29M-693K-334.16K49.95K-860.11K-2.84M-1.96M-2.15M-2.19M-1.91M-3.13M-3.72M-2.05M-6.22M-6.45M-1.97M-2.04M
Operating Margin %-376.26%----16996.85%12.83%-734.24%-235539.83%-90605.54%-13566.31%-35911.64%-1486.05%-531.92%-8790.94%-654.24%-24235.08%17059.12%-1990.48%-6474.08%
Operating Income Growth %-126.91%-796.24%-4032.89%-166.83%75.58%82.97%102.32%60.79%-48.9%37.39%42.01%-7.18%69.35%51.41%-88.57%-0.56%-396.41%-32.91%-52.78%-70.48%
EBITDA-1.48M-2.78M-1.87M-2.21M-579.06K-154.84K-145.32K-745.78K-2.74M-1.95M-2.15M-2.19M-1.9M-3.13M-3.71M-2.04M-6.21M-6.44M-1.97M-2.03M
EBITDA Margin %-349.37%----7875.99%-37.33%-636.65%-227029.79%-90255.33%-13519.35%-35797.1%-1480.99%-530.83%-8775.65%-652.49%-24213.99%17050.47%-1987.59%-6464.72%
EBITDA Growth %-155.64%-1695.91%-1185.67%-196.89%78.83%92.08%93.23%65.9%-44.01%37.5%42.11%-7.13%69.43%51.48%-88.51%-0.43%-397.14%-33.03%-53.6%-71.73%
D&A (Non-Cash Add-back)92.16K214.04K96.01K80.83K113.95K179.32K-195.27K114.33K102.55K7.58K7.46K7K6.49K6.43K6.46K5.49K5.41K3.27K2.86K2.94K
EBIT-1.57M-3.78M-2.05M-2.18M-721.22K-209.41K85.62K-951.23K-2.75M-2.05M-2.15M-2.12M-1.84M-3.4M-3.65M-2.02M-6.16M-5.91M-1.92M-2.03M
Net Interest Income-45.61K49.05K16.33K-110.27K-203.9K11.91K-175.27K-179.94K-177.63K-1.07M-1.18M-59.71K-3.95K-74K-78.37K24.26K21.96K-5.02K-29.34K-71.95K
Interest Income3.77K81.61K47.29K19.14K19.07K11.91K44.26K27.14K4.05K37.48K40.25K55.04K52.71K60.46K48.16K39.02K40.17K09.33K10.72K
Interest Expense49.38K32.55K30.96K129.41K222.97K0219.53K207.08K181.68K1.1M1.22M114.75K56.66K134.46K126.54K14.76K18.21K5.02K38.68K82.67K
Other Income/Expense-117.47K-817.55K-118.59K-14.22K-251.19K463.1K-183.86K-298.2K-89.41K-1.19M-1.21M-39.69K8.95K-405.04K-56.46K17.08K44.24K557.11K8.64K-77K
Pretax Income-1.69M-3.81M-2.08M-2.31M-944.19K128.94K-133.92K-1.16M-2.93M-3.15M-3.37M-2.23M-1.9M-3.54M-3.77M-2.03M-6.17M-5.89M-1.96M-2.11M
Pretax Margin %-478.98%---6558.65%-34.4%-988.8%-242959.92%-145701.76%-21210.52%-36561.3%-1479.07%-600.69%-8924.51%-648.78%-24062.67%15585.03%-1981.75%-6719%
Income Tax0052723.63K00355-110.89K0175.31K-99981.69K0962.87K4.22K-82.45K-86.87K1.01M-75.67K-59.56K
Effective Tax Rate %0%0%-0.03%-1.02%0%0%-0.27%9.57%0%-5.56%0.03%-3.66%0%-27.21%-0.11%4.06%1.41%-17.17%3.86%2.82%
Net Income-1.56M-3.56M-2.04M-2.26M-842.08K229.3K-186.56K-942.34K-2.83M-3.11M-3.32M-2.26M-1.82M-4.86M-3.7M-1.86M-6M-7.93M-1.81M-1.97M
Net Margin %-447.63%---11663.48%-47.93%-804.44%-235203.24%-143692.1%-20885.9%-37052.07%-1421.74%-825.8%-8764.97%-594.19%-23364.93%20988.69%-1824.75%-6270.68%
Net Income Growth %-85.29%-1653.81%-994.8%-139.51%70.29%107.37%94.38%58.37%-55.41%36.04%10.46%-21.76%69.58%38.68%-105.09%5.71%-431.27%-63.61%2.14%-6.61%
Net Income (Continuing)-1.69M-3.81M-2.08M-2.33M-944.19K128.94K-134.27K-1.05M-2.93M-3.33M-3.37M-2.32M-1.9M-4.5M-3.78M-1.95M-6.09M-6.9M-1.89M-2.05M
Discontinued Operations00000000000000000000
Minority Interest2.06M2.19M2.44M2.48M2.55M-502.18K-379.14K-465.17K-305.12K-300.64K-38.26K12.3K64.02K137.55K-225.48K-153.82K-65.49K26.69K-1M-924.48K
EPS (Diluted)-0.060.13-0.05-0.13-0.060.02-0.02-0.08-0.29-0.44-0.82-0.68-0.55-1.51-1.14-0.59-2.00-3.05-0.70-0.80
EPS Growth %-2.17%655.81%-168%-62.5%79.31%103.91%97.56%88.24%47.27%70.86%28.07%-15.25%72.5%50.49%-62.86%26.25%-300%-23.48%22.22%11.11%
EPS (Basic)-0.060.13-0.05-0.13-0.060.02-0.02-0.08-0.29-0.44-0.82-0.68-0.55-1.51-1.14-0.59-2.00-3.05-0.70-0.80
Diluted Shares Outstanding25.45M23.26M23.26M17.39M14.97M13.32M12.41M11.32M9.74M7.04M4.06M3.31M3.31M3.21M3.26M3.13M2.97M2.6M2.69M2.44M
Basic Shares Outstanding25.45M23.26M23.26M17.39M14.97M13.32M12.41M11.32M9.74M7.04M4.06M3.31M3.31M3.21M3.26M3.13M2.97M2.6M2.69M2.44M
Dividend Payout Ratio--------------------